Sarah Wilson, Stephen Northey, Rachael Wakefield-Rann, Nick Florin
{"title":"Beyond molecular structure: Comparing Australian and European regulatory approaches to nano-identification and classification","authors":"Sarah Wilson, Stephen Northey, Rachael Wakefield-Rann, Nick Florin","doi":"10.1016/j.yrtph.2025.105947","DOIUrl":null,"url":null,"abstract":"<div><div>Across regulation and toxicology, nanomaterials challenge foundational assumptions about substance identity and risk assessment. Through comparing substance identification requirements across Australian and European industrial chemical regulation – the Australian Industrial Chemicals Introduction Scheme (AICIS) and the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) respectively – this article explores how legal actors have incorporated the evolving science of nanotoxicology into the identification frameworks that establish regulatory approaches. These frameworks are important as they structure how regulators delineate between ‘new’ substances requiring novel risk assessment and regulatory approval, and ‘existing’ substances that have already been assessed.</div><div>The findings reveal REACH and AICIS have created contrasting approaches to nano-identification. REACH employs a comprehensive multifactorial method aligned with emerging nanotoxicological principles, while AICIS relies on broader structure-based CAS identifiers. These frameworks differ in both factors used and the specificity of material identification. Such regulatory data discrepancies could impact nano-risk regulation, creating potential scientific and legal vulnerabilities for managing distinct nanoforms with variable risk identities in Australia's regulatory environment. This analysis shows that the effective regulation of complex materials depends not just on accurate material characterisation, but on the structural design of legal information systems that mediate between scientific knowledge and regulatory action.</div></div>","PeriodicalId":20852,"journal":{"name":"Regulatory Toxicology and Pharmacology","volume":"164 ","pages":"Article 105947"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regulatory Toxicology and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0273230025001795","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
引用次数: 0
Abstract
Across regulation and toxicology, nanomaterials challenge foundational assumptions about substance identity and risk assessment. Through comparing substance identification requirements across Australian and European industrial chemical regulation – the Australian Industrial Chemicals Introduction Scheme (AICIS) and the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) respectively – this article explores how legal actors have incorporated the evolving science of nanotoxicology into the identification frameworks that establish regulatory approaches. These frameworks are important as they structure how regulators delineate between ‘new’ substances requiring novel risk assessment and regulatory approval, and ‘existing’ substances that have already been assessed.
The findings reveal REACH and AICIS have created contrasting approaches to nano-identification. REACH employs a comprehensive multifactorial method aligned with emerging nanotoxicological principles, while AICIS relies on broader structure-based CAS identifiers. These frameworks differ in both factors used and the specificity of material identification. Such regulatory data discrepancies could impact nano-risk regulation, creating potential scientific and legal vulnerabilities for managing distinct nanoforms with variable risk identities in Australia's regulatory environment. This analysis shows that the effective regulation of complex materials depends not just on accurate material characterisation, but on the structural design of legal information systems that mediate between scientific knowledge and regulatory action.
期刊介绍:
Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.
Types of peer-reviewed articles published:
-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:
1.Factors influencing human sensitivity
2.Exposure science related to risk assessment
3.Alternative toxicological test methods
4.Frameworks for evaluation and integration of data in regulatory evaluations
5.Harmonization across regulatory agencies
6.Read-across methods and evaluations
-Contemporary Reviews on policy related Research issues
-Letters to the Editor
-Guest Editorials (by Invitation)